Alvotech (ALVOW) Return on Capital Employed (2023 - 2025)
Alvotech (ALVOW) reported Return on Capital Employed of 6.84% for Q4 2025, down 280.0% on a YoY basis from 3.8% in Q4 2024, and down 24.73% quarter-over-quarter from 9.08% in Q3 2025.
Alvotech (ALVOW) Return on Capital Employed (2023 - 2025) Analysis & Trends
Alvotech has reported Return on Capital Employed for 3 years, with the latest figure at 6.84% in Q4 2025.
- For the quarter ending Q4 2025, Return on Capital Employed fell 280.0% year-over-year to 6.84%; the trailing twelve-month figure through Dec 2025 stood at 6.84% (down 280.0% YoY), and the FY2025 full-year result was 7.45%, down 36.0% from the prior year.
- Return on Capital Employed for Q4 2025 stood at 6.84%, down from 9.08% in the prior quarter.
- The five-year high for Return on Capital Employed was 6211.87% in Q1 2024, with the low at 13818.78% in Q1 2023.
- Historically, Return on Capital Employed has averaged 233.97% across 3 years, with a median of 8.62% in 2025.
- Annual changes were most pronounced in 2024 — Return on Capital Employed jumped 2003066 bps — and 2025, when it tumbled 120265 bps.
- Alvotech's Return on Capital Employed stood at 108.48% in 2023, then surged by 109 bps to 9.64% in 2024, then retreated by 29 bps to 6.84% in 2025.
- The last three Return on Capital Employed figures came in at 6.84% (Q4 2025), 9.08% (Q3 2025), and 8.16% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 27.58% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.43% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 20.04% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 7.34% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 6.92% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -1.92% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 14.85% |
| 10 | Alvotech | - | - | -22.39 Mn | 6.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.84% |
| Sep 30, 2025 | 9.08% |
| Jun 30, 2025 | 8.16% |
| Mar 31, 2025 | 5,009.22% |
| Dec 31, 2024 | 9.64% |
| Sep 30, 2024 | -30.17% |
| Jun 30, 2024 | 362.93% |
| Mar 31, 2024 | 6,211.87% |
| Jun 30, 2023 | -108.48% |
| Mar 31, 2023 | -13,818.78% |